Columnist Jennifer Lynne interviews Debbie Murray, a New Yorker whose hemophilia B diagnosis didn't occur until she was almost 51.

University of California San Diego Health now offers a new gene therapy for hemophilia B, a bleeding disorder that prevents ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in people with hemophilia A, the ...

Life-changing gene therapies for hemophilia have become available, yet many patients and providers have not yet rushed to try ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that ...

Now that his adult sons are managing their own hemophilia care, columnist Joe MacDonald is able to consider moving for a job.

The bleeding disorder community is served through a ... What are the National Hemophilia Foundation's (NHF) priorities for 2019? Two of NHF’s key priorities for 2019 are access to care and ...

(Photo courtesy of @UCSDHealth via Facebook) Hemophilia B is a rare, inherited bleeding disorder that prevents blood from clotting properly and puts those who suffer from it in grave danger of ...

A recent study provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that saliva contains ...

Haemophilia Treatment Market Haemophilia Treatment Market Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Haemophilia ...

JW Pharmaceutical commercializes CSA test for Hemlibra patients in South Korea JW Pharmaceutical launches a new hemophilia ...

Stevens, 63, suffers from hemophilia B, a bleeding disorder caused by a genetic mutation that affects production of a type of protein known as factor 9. Over the years, bleeds have damaged his joints.